Tech Company Financing Transactions

Indi Molecular Funding Round

Merck Capital Ventures, Asset Management Ventures and Legend Capital participated in a $11.5 million Series A funding round for Indi Molecular. This VC investment round closed on 6/30/2017.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

6160 Bristol Pkwy. 200
Culver City, CA 90230
USA

Phone

(310) 417-4999

Website

www.indimolecular.com

Email Address

[email protected]

Overview

Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Albert Luderer

        

VP - Bus. Development

Michael Klimas

        

VP - R & D

Heather Agnew

        

Browse more venture capital transactions:

Prev: 6/30/2017: Super League Gaming venture capital transaction
Next: 6/30/2017: Synspira venture capital transaction

Share this article

News on VC Transactions

We do our best to report on tech company VC transactions. All VC database entries on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary